Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page
- Check6 days agoChange DetectedA new revision label, v3.5.4, was added to the page's revision history, replacing the previous label v3.5.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA site release/revision label displayed on the page footer was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded revision note indicating the current page version (v3.5.0) and removed the previous v3.4.3. This update reflects backend versioning rather than substantive changes to the study details.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page. This appears to be a versioning update rather than substantive content changes.SummaryDifference0.1%

- Check99 days agoChange DetectedThe update adds Revision: v3.4.2 and removes Revision: v3.4.1, which appears to be a minor version label change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.